Images List Premium Download Classic

Hypertension

Hypertension-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Improved therapeutic regimen for hypertension
Geneticure Llc
June 22, 2017 - N°20170175193

The invention relates to improved methods, devices, and kits for identifying and implementing an appropriate treatment regimen for subjects suffering from hypertension.
Compositions and methods of preventing erythropoietin associated hypertension
Geneticure Llc
June 22, 2017 - N°20170173150

The invention also provides a method of reducing hypertension in a mammal receiving epo, and pharmaceutical compositions containing a soluble epo-bp and/or a recognition protein that binds epo receptor on an extracellular soluble portion of the epo receptor.
Compositions comprising cyclocarya paliurus extract and preparation method and uses thereof
Infinitus (china) Company Ltd
June 22, 2017 - N°20170173103

Compositions and preparation method thereof, said compositions comprise herb extract from a mixture comprising cyclocarya paliurus leaf and one or two herbs selected from the group consisting of puerariae lobatae radix and polygonati odorati rhizoma, said compositions can treat diabetes, hyperglycemia, hypertension and/or hyperlipidemia.
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population
Pharmathen S.a.
June 15, 2017 - N°20170165315

The present invention relates to an oral applicable therapeutic dosage form, in particular an orodispersible film comprising enalapril or pharmaceutically acceptable salts thereof for use in the treatment of hypertension in a pediatric population. The pediatric population is defined from 1 to 18 years of age. The present invention also provides a method of manufacturing of such a dosage form.
Heteroaromatic compounds and their use as dopamine d1 ligands
Pharmathen S.a.
June 15, 2017 - N°20170165270

And pharmaceutically acceptable salts thereof and n-oxides thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds (n-oxides thereof or or pharmaceutically acceptable salts of the compound or the n-oxides) and the uses of such compounds (n-oxides thereof or or pharmaceutically acceptable salts of the compound or the n-oxides) for the treatment of ...
Method of treating hypertension
Cipla Limited
June 08, 2017 - N°20170157125

Disclosed herein are compositions and methods for the treatment of pulmonary hypertension, including pulmonary arterial hypertension. The methods include administering to a patient in need thereof an effective amount of anagrelide or derivative thereof. The compositions include an effective amount of anagrelide or derivative thereof, in some instances combined with one or more additional agents for the treatment of pulmonary ...
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Pyrazine derivatives
Teijin Pharma Limited
June 01, 2017 - N°20170152242

Provided is a novel pyrazine derivative represented by the following formula (i) or a pharmaceutically acceptable salt thereof, or a solvate thereof which is useful for treating or preventing diseases in which urat1 is involved, including gout, hyperuricemia, hypertension, renal diseases such as interstitial nephritis and the like, diabetes, arteriosclerosis, lesch-nyhan syndrome, and the like.
Methods and compositions for treating diseases and conditions
Afferent Pharmaceuticals Inc.
June 01, 2017 - N°20170151241

Provided herein include methods and compositions for treating diseases or conditions. In some embodiments provided are methods for treating one or more diseases or conditions selected from the group consisting of hypertension, heart failure, dyspnea, and sleep apnea. In certain embodiments provided are methods that include administering a compound of formula (i) as disclosed herein. In some embodiments provided are ...
Phoenixin peptides
Afferent Pharmaceuticals Inc.
May 25, 2017 - N°20170145083

Human phoenixin peptides, analogs and mimetics useful in production of anti-phoenixin antibodies, diagnostic screening and assays, and in modulating cellular concentration of camp, and treatment of disorders related to camp or ca2+ concentration in cells, modulating hypertension and cardiovascular function, modulating gonadotrophs and gastric emptying.
Oxytocin improves treatment of obstructive sleep apnea
Afferent Pharmaceuticals Inc.
May 25, 2017 - N°20170143790

The present disclosure provides methods for treating obstructive sleep apnea (osa) and osa induced cardiorespiratory diseases. The disclosure provides, inter alia, methods for treating or alleviating: osa or osa induced hypertension, cardiac arrhythmias, myocardial ischemia, sudden cardiac death or stroke, by administering oxytocin. The disclosure further provides methods for improving sleep satisfaction in osa patients by administering oxytocin.
Treatment of chronic kidney disease and other renal dysfunction using a gdf15 modulator
Aveo Pharmaceuticals, Inc.
May 18, 2017 - N°20170137506

The invention provides methods and compositions for treating a subject having a renal-related disorder, such as chronic kidney disease (ckd), end stage renal failure, diabetes, insulin resistance, kidney hypertrophy, kidney hypotrophy, polycystic kidney disease, proteinuria, hyperglycemia, hyperuricemia, gout, kidney stones, hypertension or hypertensive nephropathy, dyslipidemia, anemia and/or reduced erythropoietin production, iron deficiency or hyperfiltration. The methods and compositions use ...
Process for the preparation of kinase inhibitors and intermediates thereof
Aerie Pharmaceuticals, Inc.
May 18, 2017 - N°20170137384

Described are processes for the synthesis of certain compounds, useful for treating diseases, e. G. Eye disease, such as glaucoma and ocular hypertension, in a subject.
Method for treating a pulmonary hypertension condition
Gilead Sciences, Inc.
May 18, 2017 - N°20170136016

A method for treating a pulmonary hypertension condition such as pulmonary arterial hypertension (pah) in a subject comprises administering to the subject a therapeutically effective amount of ambrisentan, wherein, at baseline, time from first diagnosis of the condition in the subject is not greater than about 2 years
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Devices and methods for control of blood pressure
Vascular Dynamics, Inc.
May 18, 2017 - N°20170135829

Apparatus and methods are described, including identifying a subject as suffering from hypertension. In response to the identifying (a) a radius of curvature of a first set of at least three regions of an arterial wall of the subject is increased at a given longitudinal location, while (b) allowing the first set of regions of the arterial wall to pulsate. ...
Methods of detecting and treating pulmonary hypertension
Rensselaer Center For Translational Research, Inc.
May 11, 2017 - N°20170131289

The present disclosure describes a method of quantifying amounts of phosphopeptides using isotopically-enriched peptides as internal standards. A kit comprising at least one isotopically-enriched phosphorylated peptide can be used to quantify changes in amounts of phosphopeptides using parallel reaction monitoring mass spectrometry techniques. The invention can be used to indicate the pathologic mechanism, severity of the disease, and treatment response ...
Method for treating secondary pulmonary hypertension
Sonivie Ltd.
May 11, 2017 - N°20170128751

Method for ameliorating secondary pulmonary hypertension in a patient including determining a pulmonary vascular resistance (pvr) of the patient suffering from secondary pulmonary hypertension; assessing a change in the pvr in response to a selection treatment; and treating the patient with a pulmonary artery manipulation device to provide pulmonary artery denervation if the patient is determined to suffer from fixed ...
Lisinopril formulations
Silvergate Pharmaceuticals, Inc.
May 04, 2017 - N°20170119840

Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.
Magnesium compositions and uses thereof for neurological disorders
Neurocentria, Inc.
April 27, 2017 - N°20170112875

A composition for administration to a subject, such as oral administration to a subject, for example, has been provided. Such a composition may comprise at least one magnesium-counter ion compound. A magnesium-counter ion composition described herein may be useful for any of a variety of applications provided herein, such as maintaining, enhancing, and/or improving health, nutrition, and/or another ...
Hypotensive lipid and timolol compositions and methods of using same
Allergan, Inc.
April 27, 2017 - N°20170112853

New compositions for and methods of treating ocular hypertension provide for effective treatment of ocular hypertension often using reduced concentrations of active components. Such compositions include a timolol component and a hypotensive lipid component. The present compositions and methods are relatively straightforward, can be easily produced, for example, using conventional manufacturing techniques, and can be easily and conveniently practiced, for ...
Methods and materials for treating hypertension
Mayo Foundation For Medical Education And Research
April 27, 2017 - N°20170112564

This document provides methods and materials involved in treating hypertension (e. G., age-associated hypertension, resistant hypertension, or chronic refractory hypertension). For example, methods and materials involved in administering one or more sympatholytic agents to a patient to identify the patient as having an elevated baseline level of sympathetic nerve activity and performing renal denervation on the identified patient to reduce ...
Methods, systems and devices for treating hypertension
Rox Medical, Inc.
April 20, 2017 - N°20170106133

Provided is a method of treating arterial hypertension in a patient. The method comprises selecting a patient suffering from arterial hypertension and creating a flow pathway between a first vascular location and a second vascular location. The first vascular location comprises a source of arterial blood and the second vascular location comprises a source of venous blood. The method causes ...
Loading